A Baltimore startup developing artificial organ technology has raised about $3 million in equity funding, according to U.S. Securities and Exchange Commission documents. Medical device firm Breethe Inc. reported the round this month, which included 22 investors. This is the second funding filing of the year for Breethe, a company based at the University of Maryland, Baltimore’s BioPark. According to an SEC document filed in August, the startup previously reported seeking $3.6 million, of which…
from https://www.bizjournals.com/baltimore/news/2017/12/28/umb-startups-raises-3-million-adding-to-big-year.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/169044527492
No comments:
Post a Comment